Metastatic breast cancer: Clinical course, prognosis and therapy related to the first site of metastasis

Breast Cancer Research and Treatment

Volumn 59, Issue 3, 2000, Pages 271-278

  Solomayer, Erich Franz ^a   Diel, I J ^b   Meyberg, G C ^b   Gollan, Ch ^b   Bastert, G ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Bone metastases; Breast cancer; Clinical course; Localization of metastases; Prognosis; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE S PHASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; VISCERA;

ABDOMINAL NEOPLASMS; BONE NEOPLASMS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VISCERA;

EID: 0034097586     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006308619659     Document Type: Article

References (30)

1. 1. Galasko CSB, Doyle FH: The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. Clin Radiol 23: 295-297, 1972
2. 18Fluorine total-body scans in patients with carcinoma of the prostate. Br J Urol 43: 58-64, 1971
3. 3. Drury AB, Palmer PH, Highman WJ: Carcinomatous metastases to the vertebral bodies. J Clin Pathol 17: 448-4547, 1964
4. 4. Tofe AJ, Francis MID, Harvey WJ: Correlation of neoplasms with incidence and localization of skeletal metastases. An analysis of 1355 diphosphonate bone scans. J Nucl Med 16: 986-989, 1975
5. 5. Johnston AD: Pathology of metastatic minors in bone. Clin Orthop 73: 8-32, 1970
6. 6. Galasko CSB: Skeletal metastases. Butterworths, London, Boston, Sydney. pp. 14-21, 1986
7. 7. Nielsen OS, Munro AJ, Tannock IF: Bone metastases: Pathology and management policy. J Clin Oncol 9: 509-524, 1991
8. 8. Yamashita K, Takafumi U, Komatsubara Y, Koyama H, Inaji H, Yomenobu K, Ono K: Breast cancer with bone only metastases. Visceral metastases-free rate in relation to anatomic distribution of bone metastases. Cancer 69: 634-637, 1991
9. 9. Body JJ, Coleman RE, Picart M: Use of bisphosphonates in cancer patients. Cancer Treat Rev 22: 265-287, 1996
10. 10. Collett D: Modelling survival data in medical research. Chapman and Hall: London, 1994
11. 11. Swenerton KD, Legha SS, Smith TL, Hortobagyi GN, Gehan EA, Yap HY, Gutterman JU, Blumenschein GR: Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39: 1552-1560, 1979
12. 12. Kamby C, Vejborg I, Daugaard S: Clinical and radiological characteristics of bone metastases in breast cancer. Cancer 60: 2524-2531, 1987
13. 13. Patanaphan V, Salazar OM, Poussin-Rosillo H: Prognosticators in recurrent breast cancer. A 15-year experience with irradiation. Cancer 54: 228-234, 1984
14. 14. Scheid V, Buzdar AU, Smith TL, Hortobagyi GN: Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 58: 2589-2593, 1986
15. 15. Sherry MM, Greco FA, Johnson DA, Hainsworth JD: Metastatic breast cancer confined to the skeletal system: an indolent disease. Am J Med 81: 381-386, 1986
16. 16. Smalley RV, Scogna DM, Malmud LS: Advanced breast cancer with hone-only metastases: a chemotherapeutically responsive pattern of metastases. Am J Clin Oncol 5: 161-166, 1982
17. 17. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66, 1987
18. 18. Coleman RE, Smith P, Rubens RD: Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77: 336-340, 1998
19. 19. Kamby C: The pattern of metastases in human breast cancer: Methodological aspects and influence of prognostic factors. Cancer Treat Rev 17: 37-61, 1990
20. 20. Perez JE, Machiavelli M, Leone BA, Romero A, Rabinowich MG, Vallejo CT, Bianco A, Rodriguez R, Cuevas MA, Alvarez LA: Bone-only versus visceral only metastatic pattern in breast cancer: analysis of 150 patients. Am J Clin Oncol 13: 294-298, 1990
21. 21. Blanco G, Holli K, Heikkinen M, Kallioniemi O-P, Taskinen P: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 62: 142-146, 1990
22. 22. Fey MF, Brunner KW, Sonntag RW. Prognostic factors in metastatic breast cancer. Cancer Clin Trials 4: 237-247, 1981
23. 23. Hietanen P, Miettinen M, Mäkinen J: Survival after first recurrence in breast cancer. Eur J Cancer Clin Oncol 22: 913-919, 1986
24. 24. Clark GM, Sledge GW, Osborne CK, McGuire WL: Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5: 55-61, 1987
25. 25. Stewart TV, King RJ, Sext SA, Millis RR, Rubens RD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer 17: 449-461, 1981
26. 26. Kamby C, Andersen J, Ejlertsen B, Birkler NE, Rytter L, Zedeler K, Thorpe SM, Norgaard T, Rose C: Histological grade and steroid receptor content of primary breast cancer: Impact on prognosis and possible modes of action. Br J Cancer 58: 480-486, 1988
27. 27. Solomayer E-F, Diel IT, Wallwiener D, Bastert G: Breast cancer with skeletal metastases at initial diagnosis. Analysis to prognosis, course and therapy. Geburtsh Frauenheilk 57: 629-636, 1997
28. 28. Bundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM, Ratcliffe JG: Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 28: 690-692, 1992
29. 29. Diel IJ, Solomayer E-F, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan Ch, Pescherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5: 3914-3919, 1999
30. 30. Coleman RE: Evaluation of bone disease in breast cancer. The Breast 3: 73-78, 1994